Company
Headquarters: Beijing, China
Employees: 814
CN¥12.12 Billion
CNY as of July 1, 2025
US$1.69 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Beijing Wandong Medical Technology Co., Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic service. It offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, and mobile X-ray equipment. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. The company was founded in 1955 and is based in Beijing, China.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥1.59 B |
| EBITDA | CN¥207.6 M |
| Gross Profit TTM | CN¥576.0 M |
| Profit Margin | 10.02% |
| Operating Margin | 6.35% |
| Quarterly Revenue Growth | 21.00% |
Beijing Wandong Medical Technology Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600055 wb_incandescent